Erratum: Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions

Z Zofia Piotrowska D Daniel Shao-Weng Tan E Egbert F. Smit A Alexander I. Spira (Virginia Cancer Specialists and NEXT Oncology-Virginia, Fairfax) R Ross A. Soo (Department of Hematology–Oncology, National University Cancer Institute, Singapore) D Danny Nguyen V Victor Ho-fun Lee J James Chih-Hsin Yang (National Taiwan University Hospital, NTU Cancer Center, Taipei) V Vamsidhar Velcheti J John M. Wrangle M Mark A. Socinski M Marianna Koczywas J John E. Janik J Jeffrey Jones H Helena Alexandra Yu